Antibe Therapeutics is a diversified biotech with two best-in-class divisions in pain/inflammation and regenerative medicine.
2025/3/14 1:06:33
(ATE:TSX.V - ATBPF:OTCQX)
Analyst coverage
Streetwise Reports Articles